V. Beaumont

473 total citations
30 papers, 308 citations indexed

About

V. Beaumont is a scholar working on Molecular Biology, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, V. Beaumont has authored 30 papers receiving a total of 308 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Surgery and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in V. Beaumont's work include Cancer, Lipids, and Metabolism (4 papers), Hormonal and reproductive studies (4 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers). V. Beaumont is often cited by papers focused on Cancer, Lipids, and Metabolism (4 papers), Hormonal and reproductive studies (4 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (4 papers). V. Beaumont collaborates with scholars based in France, United States and United Kingdom. V. Beaumont's co-authors include J. L. Beaumont, B Jacotot, J. Patrick Loria, N Lemort, Jennifer L. Beaumont, M.R. Malinow, Alvan C. Hengge, Gerard P. Sexton, David A. Wilson and Barbara Upson and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Molecular Biology and Analytical Chemistry.

In The Last Decade

V. Beaumont

29 papers receiving 286 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
V. Beaumont France	8	113	92	56	50	47	30	308
B Ernst Germany	7	80 0.7×	60 0.7×	50 0.9×	118 2.4×	54 1.1×	21	386
Demin Yu China	8	260 2.3×	54 0.6×	30 0.5×	60 1.2×	63 1.3×	10	411
Mototaka Senda Japan	9	214 1.9×	59 0.6×	55 1.0×	23 0.5×	93 2.0×	10	372
Shigemi Hosogaya Japan	11	254 2.2×	52 0.6×	29 0.5×	40 0.8×	21 0.4×	28	465
Seiji Kaku Japan	15	136 1.2×	77 0.8×	19 0.3×	43 0.9×	168 3.6×	46	566
Gary L. Engelmann United States	11	182 1.6×	48 0.5×	85 1.5×	31 0.6×	81 1.7×	15	421
Michael J. Welch United States	9	45 0.4×	63 0.7×	14 0.3×	24 0.5×	13 0.3×	9	333
Ytje Y. van der Hoek Netherlands	9	128 1.1×	347 3.8×	78 1.4×	69 1.4×	65 1.4×	14	512
Taishi Yamamoto Japan	8	168 1.5×	31 0.3×	15 0.3×	55 1.1×	99 2.1×	13	383

Countries citing papers authored by V. Beaumont

Since Specialization

Citations

This map shows the geographic impact of V. Beaumont's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Beaumont with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Beaumont more than expected).

Fields of papers citing papers by V. Beaumont

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Beaumont. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Beaumont. The network helps show where V. Beaumont may publish in the future.

Co-authorship network of co-authors of V. Beaumont

This figure shows the co-authorship network connecting the top 25 collaborators of V. Beaumont. A scholar is included among the top collaborators of V. Beaumont based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Beaumont. V. Beaumont is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Beaumont, V., et al.. (2023). Application of NMR and Chemometric Analyses to Better Understand the Quality Attributes in pH and Thermally Degraded Monoclonal Antibodies. Pharmaceutical Research. 40(10). 2457–2467. 6 indexed citations

Moyle, Austin B., V. Beaumont, Haijun Liu, et al.. (2023). Characterization of Higher Order Structural Changes of a Thermally Stressed Monoclonal Antibody via Mass Spectrometry Footprinting and Other Biophysical Approaches. Analytical Chemistry. 95(46). 16840–16849. 7 indexed citations

Beaumont, V., et al.. (2020). Allosteric Impact of the Variable Insert Loop in Vaccinia H1-Related (VHR) Phosphatase. Biochemistry. 59(20). 1896–1908. 6 indexed citations

Beaumont, V., et al.. (2017). Leveraging Reciprocity to Identify and Characterize Unknown Allosteric Sites in Protein Tyrosine Phosphatases. Journal of Molecular Biology. 429(15). 2360–2372. 41 indexed citations

Eletsky, Alexander, S. Pulavarti, V. Beaumont, Paul Gollnick, & Thomas Szyperski. (2015). Solution NMR Experiment for Measurement of ¹⁵N–¹H Residual Dipolar Couplings in Large Proteins and Supramolecular Complexes. Journal of the American Chemical Society. 137(35). 11242–11245. 5 indexed citations

Atreya, Hanudatta S., Bharathwaj Sathyamoorthy, Garima Jaipuria, et al.. (2012). GFT projection NMR for efficient 1H/13C sugar spin system identification in nucleic acids. Journal of Biomolecular NMR. 54(4). 337–342. 4 indexed citations

Allegretti, Silmara Marques, V. Beaumont, Florence Robert-Gangneux, et al.. (2001). Detection of tyrosine phosphorylated proteinsin trichinella spiralisL1 larvae. Parasite. 8(2 Suppl). S59–S61. 3 indexed citations

Beaumont, J. L., et al.. (2000). [Atherosclerosis & primary hyperlipemia; 8 case reports].. PubMed. 74(3-4). 63–80.

Delplanque, Bernadette, V. Beaumont, N Lemort, & J. L. Beaumont. (1993). Lp(a) levels and antiestrogen antibodies in women with and without thrombosis in the course of oral contraception. Atherosclerosis. 100(2). 183–188. 4 indexed citations

10.

Beaumont, V., M.R. Malinow, Gerard P. Sexton, et al.. (1992). Hyperhomocyst(e)inemia, anti-estrogen antibodies and other risk factors for thrombosis in women on oral contraceptives. Atherosclerosis. 94(2-3). 147–152. 24 indexed citations

11.

Beaumont, V., N Lemort, & J. L. Beaumont. (1991). Oral contraceptives, sex steroid-induced antibodies and vascular thrombosis: Results from 1318 cases. European Heart Journal. 12(11). 1219–1224. 9 indexed citations

12.

Beaumont, V. & Jennifer L. Beaumont. (1989). [Vascular risk of oral contraceptive agents: realities and mechanisms. I. Risk evaluation].. PubMed. 18(24). 1203–6. 5 indexed citations

13.

Thorogood, Margaret, et al.. (1985). Immunogenicity and the vascular risk of oral contraceptives.. Heart. 53(5). 556–561. 7 indexed citations

14.

Beaumont, V., Bernadette Delplanque, N Lemort, & J. L. Beaumont. (1982). Blood changes in sex steroid hormone users Cirulating immune complexes induced by estrogen and progestogens and their relation to vascular thrombosis. Atherosclerosis. 44(3). 343–353. 4 indexed citations

15.

Beaumont, J. L. & V. Beaumont. (1981). Immune Reactivity and the Vascular Risk in Oral Contraceptive Users*. American journal of reproductive immunology. 1(3). 119–125. 4 indexed citations

16.

Beaumont, V., M. Bérard, & J. L. Beaumont. (1977). A Circulating Inhibitor of Post-Heparin Plasma Lipolysis in the Type IV-V Hyperlipoproteinemia Induced in Green Lymphoma-Bearing Hamsters. Atherosclerosis. 82. 262–264. 3 indexed citations

17.

Beaumont, V., B Jacotot, & J. L. Beaumont. (1976). Ischaemic disease in men and women with familial hypercholesterolaemia and xanthomatosis A comparative study of genetic and environmental factors in 274 heterozygous cases. Atherosclerosis. 24(3). 441–450. 68 indexed citations

18.

Beaumont, V., et al.. (1974). Regression de xanthomes et medicaments hypolipidemiants. Atherosclerosis. 19(1). 1–11. 10 indexed citations

19.

Beaumont, V., et al.. (1974). Comparative study of several hypolipidemic agents related to clofibrate. Atherosclerosis. 20(2). 141–153. 2 indexed citations

20.

Beaumont, J. L., et al.. (1971). Transport sanguin et mode d’action d’un médicament hypolipidémiant apparenté au Clofibrate: Le G P 45.699. Annals of Nutrition and Metabolism. 13(6). 349–363. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact